The analysis revealed that the expression of SLC39A1, SLC39A4, and SLC39A8 is tightly associated with the prognosis of LIHC, CESC, PAAD, and KIRP, respectively. Here, SLC39A4 is linked to pancreatic adenocarcinoma.